Thermogelling emulsions for vascular embolization and sustained release of drugs

Journal of Biomedical Materials Research - Part B Applied Biomaterials

Volumn 75, Issue 1, 2005, Pages 185-192

  Kan, Pei ^a   Lin, Xi Zhang ^b   Hsieh, Ming Fa ^a   Chang, Ken Yuen ^a  

^a INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

Embolization; Emulsion; Paclitaxel; Sustained release; Thermoresponsive

Indexed keywords

ANGIOGRAPHY; BIOSYNTHESIS; BLOOD; CATHETERS; CELLS; DRUG PRODUCTS; GELS; POLYETHYLENE GLYCOLS; POLYMER BLENDS; TERPOLYMERS; TUMORS;

EMBOLIZATION; PACLITAXEL; SUSTAINED RELEASE; THERMORESPONSIVE;

EMULSIONS;

ANGIOGENESIS INHIBITOR; COPOLYMER; FAT DROPLET; IODINATED POPPYSEED OIL; MACROGOL; PACLITAXEL; POLYGLACTIN; WATER;

ANGIOGENESIS; ANGIOGRAPHY; ANTIANGIOGENIC ACTIVITY; ARTICLE; ARTIFICIAL EMBOLISM; BLOOD RHEOLOGY; BLOOD VESSEL OCCLUSION; CELL GROWTH; CONTROLLED DRUG RELEASE; DRUG DEPOSITION; EMULSION; ENDOTHELIUM CELL; GELATION; GROWTH INHIBITION; HUMAN; HUMAN CELL; HUMAN UMBILICAL VEIN ENDOTHELIUM CELL; HYDROGEL; IC 50; IN VITRO STUDY; LIVER CELL CARCINOMA; NONHUMAN; POLYMERIZATION; RABBIT; RELEASE KINETICS; SUSTAINED RELEASE PREPARATION; TEMPERATURE; THERMOGELLING EMULSION; TRANSPORT KINETICS; VISCOSITY; X RAY ANGIOGRAPHY;

ANIMALS; BLOOD VESSELS; DRUG DELIVERY SYSTEMS; EMBOLIZATION, THERAPEUTIC; EMULSIONS; HYDROGELS; MAGNETIC RESONANCE SPECTROSCOPY; MOLECULAR STRUCTURE; PACLITAXEL; POLYMERS; RABBITS; TEMPERATURE; VISCOSITY;

EID: 25844439535     PISSN: 00219304     EISSN: None     Source Type: Journal    
DOI: 10.1002/jbm.b.30286     Document Type: Article

References (29)

1. Chen TH, Chen CJ, Yen MF, Lu SN, Sun CA, Huang GT, Yang PM, Lee HS, Duffy SW. Ultrasound screening and risk factors for death from hepatocellular carcinoma in a high risk group in Taiwan. Int J Cancer 2002;98:257-261.
2. Dickinson JA, Wun YT, Wong SL. Modelling death rates for carriers of hepatitis B. Epidemiol Infect 2002;128:83-92.
3. Nagao Y, Tanaka K, Kobayashi K, Kumashiro R, Sata M. A cohort study of chronic liver disease in an HCV hyperendemic area of Japan: a prospective analysis for 12 years. Int J Mol Med 2004;13:257-265.
4. Tanikawa K. The present status of treatments for hepatocellular carcinoma. Princess Takamatsu Symp 1995;25:245-252.
5. Qian J, Feng GS, Vogl T. Combined interventional therapies of hepatocellular carcinoma. World J Gastroenterol 2003;9:1885-1891.
6. Lin DY, Lin SM, Liaw YF. Non-surgical treatment of hepatocellular carcinoma. J Gastroenterol Hepatol 1997;12:S319-S328.
7. Yasuda S, Arii S, Mori A, Isobe N, Yang W, Oe H, Fujimoto A, Yonenaga Y, Sakashita H, Imamura M. Hexokinase II and VEGF expression in liver tumors: correlation with hypoxia-inducible factor 1 alpha and its significance. J Hepatol 2004; 40:117-123.
8. Suzuki H, Mori M, Kawaguchi C, Adachi M, Miura S, Ishii H., Serum vascular endothelial growth factor in the course of transcatheter arterial embolization of hepatocellular carcinoma. Int J Oncol 1999;14:1087-1090.
9. Kobayashi N, Ishii M, Ueno Y, Kisara N, Chida N, Iwasaki T, Toyota T. Co-expression of Bcl-2 protein and vascular endothelial growth factor in hepatocellular carcinomas treated by chemoembolization. Liver 1999;19:25-31.
10. Kamei S, Okada H, Inoue Y, Yoshioka T, Ogawa Y, Toguchi H. Antitumor effects of angiogenesis inhibitor TNP-470 in rabbits bearing VX-2 carcinoma by arterial administration of microspheres and oil solution. J Pharmacol Exp Ther 1993;264:469-474.
11. Yi AW, Kim YH, Kwon IC, Chung JW, Park JH, Choi YW, Jeong SY. Stable lipiodolized emulsions for hepatoma targeting and treatment by transcatheter arterial chemoembolization. J Control Release 1998;50:135-143.
12. Denkbas EB, Seyyal M, Piskin E. 5-Fluorouracil loaded chitosan microspheres for chemoembolization. J Microencapsul 1999;16:741-749.
13. Fujiwara K, Hayakawa K, Nagata Y, Hiraoka M, Nakamura T, Shimizu Y, Ikada Y. Experimental embolization of rabbit renal arteries to compare the effects of poly 1-lactic acid microspheres with and without epirubicin release against intraarterial injection of epirubicin. Cardiovasc Intervent Radiol 2000;23:218-223.
14. Burt HM, Jackson JK, Bains SK, Liggins RT, Oktaba AMC, Arsenault AL, Hunter WL. Controlled delivery of taxol from microspheres composed of a blend of ethylene-vinyl acetate copolymer and poly (d,l-lactic acid). Cancer Lett 1995;88:73-79.
15. Kassab AC, Xu K, Denkbas EB, Dou Y, Zhao S, Piskin E. Rifampicin carrying polyhydroxybutyrate microspheres as a potential chemoembolization agent. J Biomater Sci Polym Ed 1997;8:947-961.
16. Chenite A, Chaput C, Wang D, Combes C, Buschmann MD, Hoemann CD, Leroux JC, Atkinson BL, Binette F, Selmani A. Novel injectable neutral solutions of chitosan form biodegradable gels in situ. Biomaterials 2000;21:2155-2161.
17. Ruel-Gariepy E, Chenite A, Chaput C, Guirguis S, Leroux J-C. Characterization of thermosensitive chitosan gels for the sustained delivery of drugs. Int J Pharm 2000;203:89-98.
18. Miyazaki S, Suisha F, Kawasaki N, Shirakawa M, Yamatoya K, Attwood D. Thermally reversible xyloglucan gels as vehicles for rectal drug Delivery. J Control Release 1998;56:75-83.
19. Miyazaki S, Suzuki S, Kawasaki N, Endo K, Takahashi A, Attwood D. In situ gelling xyloglucan formulations for sustained release ocular delivery of pilocarpine hydrochloride. Int J Pharm 2001;229:29-36.
20. Lee DS, Shim MS, Kim SW, Lee H, Park I, Chang T. Novel thermoreversible gelation of biodegradable PLGA-block-PEO-block-PLGA triblock copolymers in aqueous solution. Macromol Rapid Commun 2001;22:587-592.
21. Zentner GM, Rathi R, Shih C, McRea JC, Seo M-H, Oh H, Rhee BG, Mestecky J, Moldoveanu Z, Morgan M, Weitman S. Biodegradable block copolymers for delivery of proteins and water-insoluble drugs. J Control Release 2001;72:203-215.
22. Jeong Y, Bae YH, Kim SW. Drug release from biodegradable injectable thermosensitive hydrogel of PEG-PLGA-PEG triblock copolymers. J Control Release 2000;63:155-163.
23. Shim MS, Lee HT, Shim WS, Park I, Lee H, Chang T, Kim SW, Lee DS. Poly(d,l-lactic acid-co-glycolic acid)-b-poly(ethylene glycol)-b-poly (d,l-lactic acid-co-glycolic acid) triblock copolymer and thermoreversible phase transition in water. J Biomed Mater Res 2002;61:188-196.
24. Soeda S, Shibata Y, Shimeno H. Inhibitory effect of oversulfated fucoidan on tube formation by human vascular endothelial cells. Biol Pharm Bull 1997;20:1131-1135.
25. Alley MC, Scudiero DA, Monks A, Hursey ML, Czerwiniski MJ, Fine DL, Abbot BJ, Mayo JG, Shoemaker RH, Boyd MR. Feasibility of drug screening with panels of human tumor cell linesusing a microculture tetrazolium assay. Cancer Res 1988; 48:589-601.
26. Wada R, Hyon SH, Ikada Y, Kinetics of diffusion-mediated drug release enhanced by matrix degradation. J Control Release 1995;37:151-160.
27. Bezemer JM, Radersma R, Grijpma DW, Dijkstra PJ, Feijen J, van Blitterswijk CA. Zero-order release of lyzozyme from poly(ethylene glycol)/poly(butylene terephthalate) matrices. J Control Release 2000;64:179-192.
28. Varelas CG, Dixon DG, Steiner CA. Zero-order release from biphasic polymer hydrogels. J Control Release 1995;37:151-160.
29. Hayot C, Farinelle S, De Decker R, Decaestecker C, Darro F, Kiss R, Van Damme M. In vitro pharmacological characterizations of the anti-angiogenic and anti-tumor cell migration properties mediated by microtubule-affecting drugs, with special emphasis on the organization of the actin cytoskeleton. Int J Oncol 2002;21:417-425.